Disease modifying anti-rheumatic drugs (DMARDs)

The prescribing guidance, formularies, pathways and information on this website have transferred from the predecessor organisations that now form NHS Central East ICB.

Guidance may not be available for all clinical topics or geographic areas. Where guidance is available, it is clearly identified as applying to Bedfordshire, Luton and Milton Keynes (BLMK), Cambridgeshire and Peterborough (C&P), Hertfordshire or Central East (CE).

Guidance labelled Central East (CE) has been harmonised and approved for use across NHS Central East ICB. Where CE guidance is not available, local arrangements for BLMK, C&P or Hertfordshire remain in place.

Azathioprine / Mercaptopurine

Bedfordshire, Luton and Milton Keynes

Azathioprine / Mercaptopurine for Renal Autoimmune Disease – Shared Care Guideline (pdf)

Azathioprine and Mercaptopurine in Inflammatory Bowel Disease (IBD) and Autoimmune Hepatitis – Shared Care Guideline (pdf)

Azathioprine for Rheumatology Conditions – Information for GPs (pdf)

Cambridgeshire and Peterborough

Azathioprine & 6-mercaptopurine for adults with inflammatory conditions – Shared Care Guidance (pdf)

Azathioprine & 6-mercaptopurine treatment for paediatric gastroenterology and hepatology patients – Shared Care Guidance (pdf)

Hertfordshire

Azathioprine / mercaptopurine – Shared Care Agreement (docx)

Ciclosporin

Cambridgeshire and Peterborough

Ciclosporin in adult services – Shared Care Guidance (pdf)

Disease-Modifying Antirheumatic Drugs (DMARDs)

Bedfordshire, Luton and Milton Keynes

Disease modifying anti-rheumatic drugs (DMARDs) – Shared Care Guideline (For patients under the care of a Specialist at Milton Keynes) (pdf)

Rheumatology – Shared Care Guideline (For patients under the care of a Specialist at Bedfordshire Hospitals NHS Foundation Trust) (pdf)

Hydroxychloroquine

Bedfordshire, Luton and Milton Keynes

Hydroxychloroquine for Rheumatology Conditions – Information for GPs (pdf)

Cambridgeshire and Peterborough

Hydroxychloroquine for patients within adult services – Shared Care Guidance (pdf)

Leflunomide

Bedfordshire, Luton and Milton Keynes

Leflunomide for Rheumatology Conditions – Information for GPs (pdf)

Cambridgeshire and Peterborough

Leflunomide for patients in adult services – Shared Care Guidance (pdf)

Hertfordshire

Leflunomide – Shared Care Agreement (docx)

Methotrexate

Bedfordshire, Luton and Milton Keynes

Methotrexate for Rheumatology Conditions – Information for GPs (For patients under the care of a Specialist at Bedford Hospital) (pdf)

Methotrexate for Rheumatology Conditions – Information for GPs (For patients under the care of a Specialist at Luton & Dunstable Hospital) (pdf)

Methotrexate for use in Crohn’s Disease – Shared Care Guideline (For Milton Keynes area only) (pdf)

Cambridgeshire and Peterborough

Methotrexate – Shared Care Guidance (pdf)

Hertfordshire

Methotrexate – Shared Care Agreement (docx)

Mycophenolate Mofetil / Mycophenolic acid

Bedfordshire, Luton and Milton Keynes

Mycophenolate for Rheumatology Conditions – Information for GPs (pdf)

Mycophenolate Mofetil / Mycophenolic acid for Renal Autoimmune Disease – Shared Care Guideline (pdf)

Cambridgeshire and Peterborough

Mycophenolate mofetil (MMF) and mycophenolic acid use in multisystem autoimmune disease – Shared Care Guidance (pdf)

Hertfordshire

Mycophenolate mofetil – Shared Care Agreement (docx)

Sulfasalazine

Bedfordshire, Luton and Milton Keynes

Sulfasalazine for Rheumatology Conditions – Information for GPs (pdf)

Cambridgeshire and Peterborough

Sulfasalazine – Shared Care Guidance (pdf)

Hertfordshire

Sulfasalazine – Shared Care Agreement (docx)